Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777851
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2021-02-25
Brief Title:
Regorafenib-pembrolizumab vs TACETARE in Intermediate Stage HCC Beyond Up-to-7
Sponsor:
Translational Research in Oncology
Organization:
Translational Research in Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-25
First Submit QC Date:
March 1 2021
Study First Post Date:
2021-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-06
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL